Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 6601-6610 of 13615

Page
per page
  1. Cy5 NHS ester
    A8108 Cy5 NHS ester
     8 Citation
    Summary: Cy5 NHS ester (sulfonated), labels primary amines.
      insoluble in H2O; insoluble in EtOH; insoluble in DMSO
  2. Diethylmaleate
    B6151 Diethylmaleate
     1 Citation
    Summary: Maleic acid diethyl ester
      insoluble in H2O; ≥51 mg/mL
  3. N-(3-pyridyl)-Indomethacin amide
    C5629 N-(3-pyridyl)-Indomethacin amide
    Summary: inhibitor of COX-2
      ≤3 mg/mL
  4. SB 200646 hydrochloride
    B5104 SB 200646 hydrochloride
    Summary: 5-HT2C/2B receptor antagonist
      <30.28 mg/mL
  5. Agomelatine
    B2262 Agomelatine
    Summary: MT1/MT2 / 5-HT2C agonist
  6. Dorzolamide
    B1279 Dorzolamide
    Target: Carbonic Anhydrases
    Summary: Carbonic anhydrase inhibitor
      ≥42.4 mg/mL
  7. Erythromycin
    B1939 Erythromycin
    Summary: macrolide antibiotic
      ≥29.5 mg/mL
  8. Capreomycin Sulfate
    B1689 Capreomycin Sulfate
    Summary: Cyclic peptide antibiotic
      insoluble in EtOH; insoluble in DMSO; ≥251.8 mg/mL
  9. BAY 2416964
    A4763 BAY 2416964
    Summary: A selective aryl hydrocarbon receptor antagonist for solid tumors
      ≥40.3 mg/mL
  10. Ethosuximide
    C6540 Ethosuximide
    Summary: An anticonvulsant primarily for the treatment of absence epilepsy
      ≥24.1 mg/mL

Items 6601-6610 of 13615

Page
per page